Enhancing Capital’s Johnson & Johnson JNJ Stock Holding History

Enhancing Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.13M	Hold	15,600	–	–	2.86%	7
2026 Q2	$3.96M	Hold	15,600	–	–	2.72%	9
2026 Q1	$3.81M	Hold	15,600	–	–	2.83%	9
2025 Q4	$3.23M	Hold	15,600	–	–	2.31%	12
2025 Q3	$2.89M	Hold	15,600	–	–	2.12%	16
2025 Q2	$2.38M	Hold	15,600	–	–	1.82%	16
2025 Q1	$2.59M	Hold	15,600	–	–	2.07%	14
2024 Q4	$2.26M	Buy	+15,600	New	+$2.42M	1.8%	17
2022 Q3	$2.55M	Hold	15,925	–	–	3.16%	7
2022 Q2	$2.83M	Sell	15,925 -8	-0.1%	-$1.42K	3.38%	7
2022 Q1	$2.82M	Hold	15,933	–	–	3.02%	6
2021 Q4	$2.73M	Buy	+15,933	New	+$2.61M	2.96%	4

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Enhancing Capital's JNJ Position: Q3 2026 in Review

Enhancing Capital held its Johnson & Johnson (JNJ) position steady in Q3 2026 at 15,600 shares worth $4.13M. The position accounts for 2.86% of the portfolio, ranked #7.

Enhancing Capital first reported a position in JNJ in Q4 2021 and has held it in 12 quarters since. 2,102 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

Enhancing Capital held 15,600 shares of Johnson & Johnson worth $4.13M as of Q3 2026.
Enhancing Capital left its Johnson & Johnson share count unchanged in Q3 2026.
Johnson & Johnson made up 2.86% of Enhancing Capital's portfolio in Q3 2026, its #7 holding.
Enhancing Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 12 quarters since.
2,102 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Enhancing Capital's 13F filing for Q3 2026, filed 26 Oct 2026.